Serum	O	0,5
samples	O	6,13
were	O	14,18
tested	O	19,25
for	O	26,29
evidence	O	30,38
of	O	39,41
infection	O	42,51
by	O	52,54
the	O	55,58
agents	O	59,65
of	O	66,68
Lyme	B-KP	69,73
disease	I-KP	74,81
(	O	82,83
B	B-KP	83,84
.	I-KP	84,85
burgdorferi	I-KP	86,97
)	O	97,98
,	O	98,99
human	B-KP	100,105
monocytic	I-KP	106,115
ehrlichiosis	I-KP	116,128
(	O	129,130
Ehrlichia	B-KP	130,139
chaffeensis	I-KP	140,151
)	O	151,152
,	O	152,153
human	B-KP	154,159
granulocytic	I-KP	160,172
ehrlichiosis	I-KP	173,185
(	O	186,187
Ehrlichia	B-KP	187,196
phagocytophila	I-KP	197,211
)	O	211,212
,	O	212,213
Rocky	B-KP	214,219
Mountain	I-KP	220,228
spotted	I-KP	229,236
fever	I-KP	237,242
(	O	243,244
Rickettsia	B-KP	244,254
rickettsii	I-KP	255,265
)	O	265,266
,	O	266,267
murine	B-KP	268,274
typhus	I-KP	275,281
(	O	282,283
Rickettsia	B-KP	283,293
typhi	I-KP	294,299
)	O	299,300
,	O	300,301
Q	B-KP	302,303
fever	I-KP	304,309
(	O	310,311
Coxiella	B-KP	311,319
burneti	I-KP	320,327
)	O	327,328
,	O	328,329
tularaemia	B-KP	330,340
(	O	341,342
Francisella	B-KP	342,353
tularensis	I-KP	354,364
)	O	364,365
and	O	366,369
babesiosis	B-KP	370,380
(	O	381,382
Babesia	B-KP	382,389
microti	I-KP	390,397
)	O	397,398
.	O	398,399

IgG	B-KP	400,403
antibodies	I-KP	404,414
against	O	415,422
antigens	B-KP	423,431
of	I-KP	432,434
E	I-KP	435,436
.	I-KP	436,437
chaffeensis	I-KP	438,449
,	O	449,450
E	B-KP	451,452
.	I-KP	452,453
phagocytophila	I-KP	454,468
,	O	468,469
R	B-KP	470,471
.	I-KP	471,472
rickettsii	I-KP	473,483
,	O	483,484
R	B-KP	485,486
.	I-KP	486,487
typhi	I-KP	488,493
,	O	493,494
C	B-KP	495,496
.	I-KP	496,497
burneti	I-KP	498,505
,	O	505,506
and	O	507,510
B	B-KP	511,512
.	I-KP	512,513
microti	I-KP	514,521
were	O	522,526
tested	O	527,533
by	O	534,536
indirect	B-KP	537,545
fluorescent	I-KP	546,557
antibody	I-KP	558,566
assays	I-KP	567,573
(	O	574,575
IFA	B-KP	575,578
)	O	578,579
,	O	579,580
as	O	581,583
previously	O	584,594
described	O	595,604
(11–14).	O	605,613

The	O	614,617
serum	O	618,623
samples	O	624,631
were	O	632,636
screened	O	637,645
against	O	646,653
F	B-KP	654,655
.	I-KP	655,656
tularensis	I-KP	657,667
by	O	668,670
an	O	671,673
agglutination	B-KP	674,687
assay	I-KP	688,693
,	O	693,694
according	O	695,704
to	O	705,707
the	O	708,711
manufacturer's	O	712,726
recommendations	O	727,742
(	O	743,744
Difco	O	744,749
Laboratories	O	750,762
,	O	762,763
Detroit	O	764,771
,	O	771,772
MI	O	773,775
,	O	775,776
USA	O	777,780
)	O	780,781
.	O	781,782

IgG	B-KP	783,786
antibodies	I-KP	787,797
against	O	798,805
the	O	806,809
Lyme	B-KP	810,814
disease	I-KP	815,822
spirochaete	B-KP	823,834
were	O	835,839
initially	O	840,849
detected	O	850,858
by	O	859,861
enzyme-linked	B-KP	862,875
immunosorbent	I-KP	876,889
assay	I-KP	890,895
(	O	896,897
ELISA	B-KP	897,902
)	O	902,903
using	O	904,909
antigens	B-KP	910,918
of	O	919,921
the	O	922,925
N40	O	926,929
strain	O	930,936
of	O	937,939
B	B-KP	940,941
.	I-KP	941,942
burgdorferi	I-KP	943,954
sensu	O	955,960
stricto	O	961,968
(	O	969,970
15	O	970,972
)	O	972,973
.	O	973,974

Briefly	O	975,982
,	O	982,983
low-passage	O	984,995
wildtype	O	996,1004
N40	O	1005,1008
was	O	1009,1012
harvested	O	1013,1022
at	O	1023,1025
log-phase	O	1026,1035
growth	O	1036,1042
,	O	1042,1043
washed	O	1044,1050
three	O	1051,1056
times	O	1057,1062
in	O	1063,1065
Hanks	B-KP	1066,1071
'	I-KP	1071,1072
balanced	I-KP	1073,1081
salt	I-KP	1082,1086
solution	I-KP	1087,1095
(	O	1096,1097
HBSS	B-KP	1097,1101
)	O	1101,1102
,	O	1102,1103
and	O	1104,1107
resuspended	O	1108,1119
in	O	1120,1122
20	O	1123,1125
times	O	1126,1131
the	O	1132,1135
original	O	1136,1144
culture	O	1145,1152
volume	O	1153,1159
in	O	1160,1162
HBSS	B-KP	1163,1167
.	O	1167,1168
The	O	1169,1172
washed	O	1173,1179
spirochaetes	B-KP	1180,1192
were	O	1193,1197
sonicated	O	1198,1207
on	O	1208,1210
ice	O	1211,1214
until	O	1215,1220
darkfield	B-KP	1221,1230
microscopy	I-KP	1231,1241
indicated	O	1242,1251
that	O	1252,1256
>85%	O	1257,1261
of	O	1262,1264
the	O	1265,1268
organisms	O	1269,1278
had	O	1279,1282
been	O	1283,1287
disrupted	O	1288,1297
.	O	1297,1298

After	O	1299,1304
centrifugation	O	1305,1319
to	O	1320,1322
remove	O	1323,1329
fragments	O	1330,1339
and	O	1340,1343
whole	O	1344,1349
spirochaetes	B-KP	1350,1362
,	O	1362,1363
the	O	1364,1367
soluble	O	1368,1375
extract	O	1376,1383
was	O	1384,1387
aliquoted	O	1388,1397
and	O	1398,1401
stored	O	1402,1408
at	O	1409,1411
–	O	1412,1413
20C	O	1413,1416
.	O	1416,1417
Microtitre	O	1418,1428
plates	O	1429,1435
(	O	1436,1437
Immulon	O	1437,1444
4	O	1445,1446
,	O	1446,1447
Dynex	O	1448,1453
,	O	1453,1454
Chantilly	O	1455,1464
,	O	1464,1465
VA	O	1466,1468
,	O	1468,1469
USA	O	1470,1473
)	O	1473,1474
were	O	1475,1479
coated	O	1480,1486
with	O	1487,1491
250	O	1492,1495
mg	O	1496,1498
of	O	1499,1501
antigen	B-KP	1502,1509
per	O	1510,1513
well	O	1514,1518
and	O	1519,1522
allowed	O	1523,1530
to	O	1531,1533
dry	O	1534,1537
.	O	1537,1538

The	O	1539,1542
plates	O	1543,1549
were	O	1550,1554
blocked	O	1555,1562
with	O	1563,1567
5	O	1568,1569
%	O	1569,1570
donor	O	1571,1576
horse	O	1577,1582
serum	O	1583,1588
,	O	1588,1589
1	O	1590,1591
%	O	1591,1592
dextran	O	1593,1600
sulfate	O	1601,1608
in	O	1609,1611
PBS-Tween	O	1612,1621
20	O	1622,1624
.	O	1624,1625

Sera	O	1626,1630
were	O	1631,1635
diluted	O	1636,1643
in	O	1644,1646
this	O	1647,1651
blocking	O	1652,1660
buffer	O	1661,1667
at	O	1668,1670
1:100,	O	1671,1677
added	O	1678,1683
to	O	1684,1686
wells	O	1687,1692
in	O	1693,1695
triplicate	O	1696,1706
,	O	1706,1707
and	O	1708,1711
incubated	O	1712,1721
for	O	1722,1725
1	O	1726,1727
hour	O	1728,1732
.	O	1732,1733

Bound	O	1734,1739
antibody	B-KP	1740,1748
was	O	1749,1752
detected	O	1753,1761
by	O	1762,1764
the	O	1765,1768
addition	O	1769,1777
of	O	1778,1780
alkaline	B-KP	1781,1789
phosphatase-conjugated	I-KP	1790,1812
goat	I-KP	1813,1817
antihuman	I-KP	1818,1827
IgG	I-KP	1828,1831
(	O	1832,1833
Kirkegaard	O	1833,1843
&	O	1844,1845
Perry	O	1846,1851
Laboratories	O	1852,1864
,	O	1864,1865
Gaithersburg	O	1866,1878
,	O	1878,1879
MD	O	1880,1882
,	O	1882,1883
USA	O	1884,1887
)	O	1887,1888
,	O	1888,1889
as	O	1890,1892
recommended	O	1893,1904
by	O	1905,1907
the	O	1908,1911
manufacturer	O	1912,1924
.	O	1924,1925

A	O	1926,1927
p-nitrophenyl	B-KP	1928,1941
phosphate	I-KP	1942,1951
substrate	I-KP	1952,1961
in	I-KP	1962,1964
diethanolamine	I-KP	1965,1979
buffer	I-KP	1980,1986
was	O	1987,1990
used	O	1991,1995
to	O	1996,1998
visualize	O	1999,2008
bound	O	2009,2014
secondary	B-KP	2015,2024
antibody	I-KP	2025,2033
when	O	2034,2038
the	O	2039,2042
reactions	O	2043,2052
were	O	2053,2057
terminated	O	2058,2068
at	O	2069,2071
30	O	2072,2074
minutes	O	2075,2082
,	O	2082,2083
and	O	2084,2087
read	O	2088,2092
promptly	O	2093,2101
at	O	2102,2104
l	O	2105,2106
=	O	2107,2108
405	O	2109,2112
nm	O	2113,2115
.	O	2115,2116

Negative	O	2117,2125
control	O	2126,2133
sera	O	2134,2138
(	O	2139,2140
n	O	2140,2141
=	O	2142,2143
6	O	2144,2145
)	O	2145,2146
,	O	2146,2147
taken	O	2148,2153
from	O	2154,2158
laboratory	O	2159,2169
staff	O	2170,2175
members	O	2176,2183
with	O	2184,2188
no	O	2189,2191
history	O	2192,2199
of	O	2200,2202
Lyme	B-KP	2203,2207
disease	I-KP	2208,2215
,	O	2215,2216
were	O	2217,2221
analysed	O	2222,2230
on	O	2231,2233
each	O	2234,2238
plate	O	2239,2244
.	O	2244,2245

A	O	2246,2247
serum	O	2248,2253
sample	O	2254,2260
was	O	2261,2264
considered	O	2265,2275
reactive	O	2276,2284
if	O	2285,2287
its	O	2288,2291
mean	O	2292,2296
absorbance	O	2297,2307
exceeded	O	2308,2316
3	O	2317,2318
standard	O	2319,2327
deviations	O	2328,2338
of	O	2339,2341
the	O	2342,2345
mean	O	2346,2350
of	O	2351,2353
the	O	2354,2357
18	O	2358,2360
(	O	2361,2362
6	O	2362,2363
x	O	2364,2365
3	O	2366,2367
)	O	2367,2368
negative	O	2369,2377
control	O	2378,2385
wells	O	2386,2391
,	O	2391,2392
calculated	O	2393,2403
for	O	2404,2407
each	O	2408,2412
microtitre	O	2413,2423
plate	O	2424,2429
.	O	2429,2430

